Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XPANCEO is a deep-tech company specializing in the development of the next generation of smart contact lenses using advanced 2D materials and nanophotonics. The company aims to integrate high-tech capabilities—such as augmented reality, health monitoring, and vision correction—into a single, ultra-thin, and comfortable lens. Their technology focuses on non-invasive monitoring of biomarkers like glucose and intraocular pressure, alongside providing digital content overlays. Headquartered in Dubai, XPANCEO leverages a multidisciplinary team of scientists and engineers to transition from traditional bulky wearables to invisible, seamless interfaces.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XPANCEO.